• Issues related to health care, the Food and Drug Administration (FDA), drug pricing and the 340b program. HR 878, Trickett Wendler Right to Try Act of 2017/S. 204, Trickett Wendler, Frank Mongiello, Jordan McLinn and Matthew Bellina Right to Try Act of 2017 (P.L. 115-176); S. 2852, Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018
• S. 3158, Departments of Labor, Health & Human Services, and Education, and Related Agencies Appropriations Act of 2019; HR 5961/S. 2976, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2019
• Implementation of H.R. 1, Tax Cuts and Job Act (P.L. 115-97)
• Part D Medicare program and Medicare reimbursement issues

Duration: January 7, 2010 to January 1, 2019

General Issues: Health Issues, Budget/Appropriations, Taxation/Internal Revenue Code, Medicare/Medicaid, Pharmacy

Spending: about $1,360,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2010: U.S. Senate, House of Representatives, Food & Drug Administration (FDA)